Overall survival and current management of breast cancer in elderly Ivoirian's women

Abstract Objective To present the epidemioclinical features, the immunohistochemical profile and the overall survival rate of women over 65 with breast cancer. Materials and methods In a retrospective study, we recruited women over 65 years old with breast cancer who were treated in the district of Abidjan. Our study took place in a period of 60 months, from 2014 until 2018. The patients were selected from several sources; namely the consultation\u0027s registers, the hospitalization\u0027s units, the operating theater and the archive files of all the above. The data were collected using a survey sheet, processed then analyzed from the Epi info7 software. The Kaplan–Meier test helped us appreciate the survival. Results From a total of 2233 breast cancers, we got 52 patients over the age of 65, i.e. a proportion of 9.53%. These patients’ age range was between 65 and 86 years old with an average age of 72 years old. The non-specific invasive carcinoma represented the most frequent histological type with 94.23% of the cases. 1 out of 2 women (56.41%) received a neoadjuvant chemotherapy. The overall survival rate for 5 years were 9.62%. The median survival of the patients was 15.50 months. The immunohistochemical profile was determined for 21 patients and among them there was no Luminal B Her 2- and the Luminal A (43%) was the dominant profile. Conclusion The management of elderly Ivoirian breast cancer was essentially non-surgical with a low survival.